Discovery of a novel piperazine derivative, cmp2: a selective TRPC6 activator suitable for treatment of synaptic deficiency in Alzheimer's disease hippocampal neurons.

Saved in:
Bibliographic Details
Title: Discovery of a novel piperazine derivative, cmp2: a selective TRPC6 activator suitable for treatment of synaptic deficiency in Alzheimer's disease hippocampal neurons.
Authors: Zernov, Nikita1 (AUTHOR), Ghamaryan, Viktor2 (AUTHOR), Melenteva, Daria1 (AUTHOR), Makichyan, Ani2 (AUTHOR), Hunanyan, Lernik2 (AUTHOR), Popugaeva, Elena1 (AUTHOR) lena.popugaeva@gmail.com
Source: Scientific Reports. 10/12/2024, Vol. 14 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-024-73849-z